Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	PCDHGC4 CD248 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 CRTAC1 DYSF PCDHB18P PCDHGA12 ACAN CDH3 PCDHGA8 NOTCH4 CDHR4	1.44e-05	749	165	19	GO:0005509
GeneOntologyMolecularFunction	cytoskeletal protein binding	NPHS1 MAGI1 MYOT NRCAM MID2 CEACAM6 DYSF ACTR3 CEACAM1 TTLL7 MYO5C BICD1 WASH6P SHROOM1 LLGL2 NF1 BAIAP2L1 STARD9 WASF2 SSH2 GOLGA8A FRMD3 CFAP157	3.75e-05	1099	165	23	GO:0008092
GeneOntologyMolecularFunction	SUMO transferase activity	ZMIZ1 PIAS1 ZMIZ2 PML	2.15e-04	36	165	4	GO:0019789
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	MYOT NRCAM PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 CEACAM6 CEACAM1 PCDHB18P PCDHGA12 IGSF9B CDH3 PCDHGA8 CDHR4	8.29e-16	187	166	19	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	MYOT NRCAM PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 CEACAM6 CEACAM1 PCDHB18P PCDHGA12 IGSF9B CDH3 PCDHGA8 CDHR4	9.19e-12	313	166	19	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	NPHS1 MAGI1 MYOT NRCAM PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 CEACAM6 ZMIZ1 KIRREL2 CEACAM1 PCDHB18P BAIAP2L1 EGR3 PCDHGA12 IGSF9B NFAT5 CDH3 PCDHGA8 AP3D1 NOTCH4 CDHR4 PEAR1	9.35e-09	1077	166	29	GO:0098609
HumanPheno	Asthma	CLCA4 CEACAM6 SIK3 CDC42BPB CREBBP JMJD1C STAT6 BCL11B FCGR2A	3.34e-05	164	52	9	HP:0002099
HumanPheno	Short philtrum	EMC1 PCDHGC4 MID2 SMC1A IQSEC2 CDC42BPB CREBBP JMJD1C KCNK4 FREM1 BCL11B	3.59e-05	253	52	11	HP:0000322
Domain	Cadherin	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 FREM3 FREM1 PCDHGA12 CDH3 PCDHGA8 CDHR4	6.45e-14	118	157	15	IPR002126
Domain	Cadherin_CS	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 PCDHGA12 CDH3 PCDHGA8 CDHR4	7.39e-12	109	157	13	IPR020894
Domain	CADHERIN_1	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 PCDHGA12 CDH3 PCDHGA8 CDHR4	1.18e-11	113	157	13	PS00232
Domain	Cadherin	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 PCDHGA12 CDH3 PCDHGA8 CDHR4	1.18e-11	113	157	13	PF00028
Domain	CADHERIN_2	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 PCDHGA12 CDH3 PCDHGA8 CDHR4	1.32e-11	114	157	13	PS50268
Domain	-	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 PCDHGA12 CDH3 PCDHGA8 CDHR4	1.32e-11	114	157	13	2.60.40.60
Domain	CA	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 PCDHGA12 CDH3 PCDHGA8 CDHR4	1.48e-11	115	157	13	SM00112
Domain	Cadherin-like	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 FAT3 PCDHB4 PCDHGA12 CDH3 PCDHGA8 CDHR4	1.65e-11	116	157	13	IPR015919
Domain	Cadherin_tail	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHGA12 PCDHGA8	1.69e-11	37	157	9	PF15974
Domain	Cadherin_CBD	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHGA12 PCDHGA8	1.69e-11	37	157	9	IPR031904
Domain	Cadherin_C	PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHGA12 PCDHGA8	5.85e-11	42	157	9	IPR032455
Domain	Cadherin_C_2	PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHGA12 PCDHGA8	5.85e-11	42	157	9	PF16492
Domain	Cadherin_2	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHGA12 PCDHGA8	1.59e-10	65	157	10	PF08266
Domain	Cadherin_N	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHGA12 PCDHGA8	1.59e-10	65	157	10	IPR013164
Domain	IGc2	NPHS1 LILRA2 MYOT NRCAM SPEG CEACAM6 KIRREL2 CEACAM1 SIGLEC7 FCGR2A IGSF9B	4.94e-06	235	157	11	SM00408
Domain	Ig_sub2	NPHS1 LILRA2 MYOT NRCAM SPEG CEACAM6 KIRREL2 CEACAM1 SIGLEC7 FCGR2A IGSF9B	4.94e-06	235	157	11	IPR003598
Domain	zf-MIZ	ZMIZ1 PIAS1 ZMIZ2	1.99e-05	7	157	3	PF02891
Domain	ZF_SP_RING	ZMIZ1 PIAS1 ZMIZ2	1.99e-05	7	157	3	PS51044
Domain	-	DOK1 DOK6 IQSEC2 DOCK10 APBA3 TNS2 CDC42BPB RGS3 IRS2 PLEKHM3 SKAP2 GAB1 FRMD3	2.72e-05	391	157	13	2.30.29.30
Domain	Znf_MIZ	ZMIZ1 PIAS1 ZMIZ2	3.16e-05	8	157	3	IPR004181
Domain	Ig_I-set	NPHS1 MYOT NRCAM SPEG CEACAM6 KIRREL2 CEACAM1 SIGLEC7 IGSF9B	3.35e-05	190	157	9	IPR013098
Domain	I-set	NPHS1 MYOT NRCAM SPEG CEACAM6 KIRREL2 CEACAM1 SIGLEC7 IGSF9B	3.35e-05	190	157	9	PF07679
Domain	Ig_2	LILRA2 CEACAM6 CEACAM1 SIGLEC7 FCGR2A IGSF9B	3.43e-05	73	157	6	PF13895
Domain	-	NPHS1 EPOR LILRA2 MYOT NRCAM MID2 MYCBP2 SPEG CEACAM6 KIRREL2 CEACAM1 SIGLEC7 FCGR2A ROS1 IGSF9B HCFC2 NFAT5	4.42e-05	663	157	17	2.60.40.10
Domain	PH_dom-like	DOK1 DOK6 IQSEC2 DOCK10 APBA3 TNS2 CDC42BPB RGS3 IRS2 PLEKHM3 SKAP2 GAB1 FRMD3	6.55e-05	426	157	13	IPR011993
Domain	fn3	NPHS1 EPOR NRCAM MID2 SPEG ROS1 IGSF9B HCFC2	6.90e-05	162	157	8	PF00041
Domain	PTBI	DOK1 DOK6 IRS2	9.15e-05	11	157	3	SM00310
Domain	Ig-like_fold	NPHS1 EPOR LILRA2 MYOT NRCAM MID2 MYCBP2 SPEG CEACAM6 KIRREL2 CEACAM1 SIGLEC7 FCGR2A ROS1 IGSF9B HCFC2 NFAT5	9.55e-05	706	157	17	IPR013783
Domain	IRS_PTB	DOK1 DOK6 IRS2	1.21e-04	12	157	3	PS51064
Domain	FN3	NPHS1 EPOR NRCAM MID2 SPEG ROS1 IGSF9B HCFC2	1.73e-04	185	157	8	SM00060
Domain	IRS	DOK1 DOK6 IRS2	1.98e-04	14	157	3	PF02174
Domain	IRS_PTB	DOK1 DOK6 IRS2	1.98e-04	14	157	3	IPR002404
Domain	FN3	NPHS1 EPOR NRCAM MID2 SPEG ROS1 IGSF9B HCFC2	2.85e-04	199	157	8	PS50853
Domain	FN3_dom	NPHS1 EPOR NRCAM MID2 SPEG ROS1 IGSF9B HCFC2	3.95e-04	209	157	8	IPR003961
Domain	Glyco_hydro_31_CS	MGAM GAA	4.17e-04	4	157	2	IPR030459
Domain	Gal_mutarotase_N	MGAM GAA	4.17e-04	4	157	2	IPR031727
Domain	NtCtMGAM_N	MGAM GAA	4.17e-04	4	157	2	PF16863
Domain	PH	DOK1 DOK6 IQSEC2 DOCK10 CDC42BPB IRS2 PLEKHM3 SKAP2 GAB1	5.86e-04	278	157	9	SM00233
Domain	PH_DOMAIN	DOK1 DOK6 IQSEC2 DOCK10 CDC42BPB IRS2 PLEKHM3 SKAP2 GAB1	6.01e-04	279	157	9	PS50003
Domain	PH_domain	DOK1 DOK6 IQSEC2 DOCK10 CDC42BPB IRS2 PLEKHM3 SKAP2 GAB1	6.17e-04	280	157	9	IPR001849
Domain	GLYCOSYL_HYDROL_F31_2	MGAM GAA	6.91e-04	5	157	2	PS00707
Domain	PH	DOK1 DOK6 DOCK10 CDC42BPB IRS2 PLEKHM3 SKAP2 GAB1	7.22e-04	229	157	8	PF00169
Domain	IG	NPHS1 LILRA2 MYOT NRCAM SPEG CEACAM6 KIRREL2 CEACAM1 SIGLEC7 FCGR2A IGSF9B	8.84e-04	421	157	11	SM00409
Domain	Ig_sub	NPHS1 LILRA2 MYOT NRCAM SPEG CEACAM6 KIRREL2 CEACAM1 SIGLEC7 FCGR2A IGSF9B	8.84e-04	421	157	11	IPR003599
Domain	Glyco_hydro_31_AS	MGAM GAA	1.03e-03	6	157	2	IPR030458
Domain	ig	NPHS1 LILRA2 NRCAM CEACAM6 CEACAM1 SIGLEC7 FCGR2A	1.14e-03	190	157	7	PF00047
Domain	Immunoglobulin	NPHS1 LILRA2 NRCAM CEACAM6 CEACAM1 SIGLEC7 FCGR2A	1.14e-03	190	157	7	IPR013151
Domain	Glyco_hydro_31	MGAM GAA	1.43e-03	7	157	2	IPR000322
Domain	Glyco_hydro_31	MGAM GAA	1.43e-03	7	157	2	PF01055
Domain	GLYCOSYL_HYDROL_F31_1	MGAM GAA	1.43e-03	7	157	2	PS00129
Domain	P_TREFOIL_1	MGAM GAA	1.90e-03	8	157	2	PS00025
Domain	Trefoil	MGAM GAA	1.90e-03	8	157	2	PF00088
Domain	P_trefoil_CS	MGAM GAA	1.90e-03	8	157	2	IPR017957
Domain	PAS	HIF3A PASD1 ARNT2	2.42e-03	32	157	3	SM00091
Domain	Calx_beta	FREM3 FREM1	2.43e-03	9	157	2	IPR003644
Domain	P_TREFOIL_2	MGAM GAA	2.43e-03	9	157	2	PS51448
Domain	Calx-beta	FREM3 FREM1	2.43e-03	9	157	2	PF03160
Domain	PD	MGAM GAA	2.43e-03	9	157	2	SM00018
Pathway	REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K	EPOR IRS2 GAB1	8.65e-05	12	106	3	M27905
Pathway	REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K	EPOR IRS2 GAB1	8.65e-05	12	106	3	MM15623
Pathway	REACTOME_RET_SIGNALING	DOK1 DOK6 IRS2 GAB1	1.83e-04	38	106	4	MM15493
Pathway	PID_RET_PATHWAY	DOK1 DOK6 IRS2 GAB1	2.03e-04	39	106	4	M82
Pathway	REACTOME_RET_SIGNALING	DOK1 DOK6 IRS2 GAB1	2.24e-04	40	106	4	M27746
Pathway	REACTOME_SIGNALING_BY_ERYTHROPOIETIN	EPOR IRS2 GAB1	2.60e-04	17	106	3	MM15584
Pathway	PID_TCPTP_PATHWAY	PIAS1 CREBBP STAT6 GAB1	2.71e-04	42	106	4	M91
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHB18P PCDHGA12 PCDHGA8	2.71e-14	68	167	11	11230163
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHB18P PCDHGA12 PCDHGA8	5.26e-14	72	167	11	10380929
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHB18P PCDHGA12 PCDHGA8	7.22e-14	74	167	11	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHB18P PCDHGA12 PCDHGA8	1.14e-13	77	167	11	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHB18P PCDHGA12 PCDHGA8	1.76e-13	80	167	11	10716726
Pubmed	Maturation of postnatally generated olfactory bulb granule cells depends on functional γ-protocadherin expression.	PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA3 PCDHGA12	6.94e-09	15	167	5	23515096
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA3 PCDHB4 PCDHB18P PCDHGA12	1.12e-08	57	167	7	32633719
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DMXL2 EMC1 RPAP3 DHX38 DOCK10 COLGALT2 SIK3 PIAS1 JMJD1C RGS3 WASH6P LLGL2 NUP155 AP1B1 WASHC5 WASF2 AP3D1	1.86e-08	650	167	17	38777146
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CDV3 DYNC2I2 RPAP3 SEC24A TNRC6C SIK3 ACTR3 BICD1 MICALL1 ARHGAP5 BAIAP2L1 WASHC5 WASF2 HGS SIPA1L2 PCCB FHIP1A PDZRN3	1.75e-07	853	167	18	28718761
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAGI1 EMC1 MYCBP2 SEC24A IQSEC2 SIK3 C6orf132 MICALL1 FSIP2 NF1 BAIAP2L1 STARD9 IRS2 PLEKHM3 SSH2 SIPA1L2 GAB1 PML	2.00e-07	861	167	18	36931259
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA3 PCDHGA12	2.16e-07	28	167	5	15347688
Pubmed	Functional significance of isoform diversification in the protocadherin gamma gene cluster.	PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA3 PCDHGA12	5.98e-07	34	167	5	22884324
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DMXL2 MYCBP2 SMC1A DOCK10 TNRC6C SIK3 CDC42BPB TPCN1 RBM12	1.56e-06	225	167	9	12168954
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYCBP2 SPEG DUSP5 TNRC6C DYSF CDC42BPB C6orf132 TPCN1 GGT7 MICALL1 PCNX2 LLGL2 ZMIZ2 ANKRD34A RIPOR1 IRS2 SIPA1L2 AP3D1 PKN3	1.70e-06	1105	167	19	35748872
Pubmed	Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.	EPOR IRS2 GAB1	2.15e-06	6	167	3	12506011
Pubmed	WASH complex regulates Arp2/3 complex for actin-based polar body extrusion in mouse oocytes.	ACTR3 WASH6P WASHC5	2.15e-06	6	167	3	24998208
Pubmed	A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription.	ZMIZ1 PIAS1 ZMIZ2	2.15e-06	6	167	3	20159969
Pubmed	A differential developmental pattern of spinal interneuron apoptosis during synaptogenesis: insights from genetic analyses of the protocadherin-gamma gene cluster.	PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA3 PCDHGA12	2.24e-06	44	167	5	19029045
Pubmed	FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction.	CREBBP IRS2 PML	3.75e-06	7	167	3	16154098
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TNRC6C ZMIZ1 CREBBP JMJD1C MED15 RBM12 ZMIZ2	9.35e-06	152	167	7	38360978
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	CDV3 RPAP3 DHX38 DDX42 PIAS1 CREBBP JMJD1C MED15 RNF220 RBM12 PML	1.10e-05	444	167	11	34795231
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	DYNC2I2 RPAP3 SEC24A IQSEC2 RBM26 APBA3 TNRC6C ACTR3 CLASRP SHROOM1 AP1B1 WASHC5 UTP4 RIPOR1 IRS2 SSH2 AP3D1	1.16e-05	1038	167	17	26673895
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	EMC1 MYCBP2 RPAP3 SEC24A DUSP5 DHX38 TNS2 CDC42BPB ACTR3 PTPN5 ARHGAP5 NUP155 WASHC5 HGS INTS4 SSH2 GAB1	1.33e-05	1049	167	17	27880917
Pubmed	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	MAGI1 FAT3 PCNX2 NFAT5	1.88e-05	33	167	4	24204828
Pubmed	Investigation of the interaction between CREB-binding protein and STAT4/STAT6.	CREBBP STAT6	2.29e-05	2	167	2	21140220
Pubmed	A fraction of neurofibromin interacts with PML bodies in the nucleus of the CCF astrocytoma cell line.	NF1 PML	2.29e-05	2	167	2	22293200
Pubmed	Induction of Fc gammaRIIA expression in myeloid PLB cells during differentiation depends on cytosolic phospholipase A2 activity and is regulated via activation of CREB by PGE2.	CREBBP FCGR2A	2.29e-05	2	167	2	16709925
Pubmed	Functions of the podocyte proteins nephrin and Neph3 and the transcriptional regulation of their genes.	NPHS1 KIRREL2	2.29e-05	2	167	2	24219158
Pubmed	Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes.	EPOR TFR2	2.29e-05	2	167	2	26914246
Pubmed	Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease.	CEACAM6 CEACAM1	2.29e-05	2	167	2	17960155
Pubmed	T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction.	CEACAM6 CEACAM1	2.29e-05	2	167	2	35141051
Pubmed	Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.	CREBBP PML	2.29e-05	2	167	2	10077561
Pubmed	An assessment of progress in the use of alternatives in toxicity testing since the publication of the report of the second FRAME Toxicity Committee (1991).	CREBBP PML	2.29e-05	2	167	2	12234245
Pubmed	CD66 identifies the biliary glycoprotein (BGP) adhesion molecule: cloning, expression, and adhesion functions of the BGPc splice variant.	CEACAM6 CEACAM1	2.29e-05	2	167	2	8018919
Pubmed	ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses.	F5 ROS1	2.29e-05	2	167	2	29945753
Pubmed	The possible involvement of tensin2 in the expression and extension of nephrin by glomerular podocytes in mice.	NPHS1 TNS2	2.29e-05	2	167	2	19129671
Pubmed	CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma.	CREBBP STAT6	2.29e-05	2	167	2	32555149
Pubmed	Novel interaction between nuclear coactivator CBP and the protein inhibitor of activated Stat1 (PIAS1).	PIAS1 CREBBP	2.29e-05	2	167	2	15957955
Pubmed	Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells.	CEACAM6 CEACAM1	2.29e-05	2	167	2	28292985
Pubmed	C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation.	NPHS1 TNS2	2.29e-05	2	167	2	28955049
Pubmed	CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells.	CEACAM6 CEACAM1	2.29e-05	2	167	2	16115956
Pubmed	The Rho GTPase Rif signals through IRTKS, Eps8 and WAVE2 to generate dorsal membrane ruffles and filopodia.	BAIAP2L1 WASF2	2.29e-05	2	167	2	27278019
Pubmed	Spatial and temporal expression of Zimp7 and Zimp10 PIAS-like proteins in the developing mouse embryo.	ZMIZ1 ZMIZ2	2.29e-05	2	167	2	18053775
Pubmed	Differential expression of the suppressor PML and Ki-67 identifies three subtypes of human nasopharyngeal carcinoma.	CREBBP PML	2.29e-05	2	167	2	12142048
Pubmed	The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex.	ACTR3 WASH6P WASHC5	2.32e-05	12	167	3	19922875
Pubmed	Arp2/3 inactivation causes intervertebral disc and cartilage degeneration with dysregulated TonEBP-mediated osmoadaptation.	ACTR3 ACAN NFAT5	3.00e-05	13	167	3	31961823
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	MAGI1 RPAP3 SEC24A SMC1A JMJD1C MICALL1 NUP155 BAIAP2L1 WASF2 HGS IRS2 AP3D1 GAB1	4.11e-05	708	167	13	39231216
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	PIAS1 C6orf132 TMEM132C NUP155 BAIAP2L1 ZMIZ2 IGSF9B SAP130 FHIP1A GAB1	4.74e-05	430	167	10	35044719
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	MAGI1 DYNC2I2 CDC42BPB ACTR3 NF1 AP1B1 STARD9 ACAN SIPA1L2 AP3D1	4.74e-05	430	167	10	32581705
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	DDX42 RBM26 CREBBP JMJD1C MED15 RBM12 INTS4 SAP130	4.93e-05	268	167	8	33640491
Pubmed	Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme.	NF1 GAA	6.85e-05	3	167	2	12409258
Pubmed	PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool.	STAT6 PML	6.85e-05	3	167	2	19261859
Pubmed	Antibody ligation of CEACAM1, CEACAM3, and CEACAM6, differentially enhance the cytokine release of human neutrophils in responses to Candida albicans.	CEACAM6 CEACAM1	6.85e-05	3	167	2	34847408
Pubmed	The Src substrate SKAP2 regulates actin assembly by interacting with WAVE2 and cortactin proteins.	WASF2 SKAP2	6.85e-05	3	167	2	23161539
Pubmed	Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia.	CREBBP BCL11B	6.85e-05	3	167	2	21080944
Pubmed	Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer.	CEACAM6 CEACAM1	6.85e-05	3	167	2	25409014
Pubmed	GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin alpha5beta1-fibronectin interaction.	CEACAM6 CEACAM1	6.85e-05	3	167	2	17167768
Pubmed	A WAVE2-Arp2/3 actin nucleator apparatus supports junctional tension at the epithelial zonula adherens.	ACTR3 WASF2	6.85e-05	3	167	2	23051739
Pubmed	Transcriptional activation by STAT6 requires the direct interaction with NCoA-1.	CREBBP STAT6	6.85e-05	3	167	2	11574547
Pubmed	Ptf1a directly controls expression of immunoglobulin superfamily molecules Nephrin and Neph3 in the developing central nervous system.	NPHS1 KIRREL2	6.85e-05	3	167	2	19887377
Pubmed	PML-nuclear bodies are involved in cellular serum response.	CREBBP PML	6.85e-05	3	167	2	12622724
Pubmed	Defining the roles of human carcinoembryonic antigen-related cellular adhesion molecules during neutrophil responses to Neisseria gonorrhoeae.	CEACAM6 CEACAM1	6.85e-05	3	167	2	22064717
Pubmed	Erythropoietin signaling: a novel regulator of white adipose tissue inflammation during diet-induced obesity.	EPOR STAT6	6.85e-05	3	167	2	24647735
Pubmed	Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.	DYSF GAA	6.85e-05	3	167	2	20413686
Pubmed	UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia.	UBA7 PML	6.85e-05	3	167	2	11891284
Pubmed	Engagement of Gab1 and Gab2 in erythropoietin signaling.	EPOR GAB1	6.85e-05	3	167	2	10455108
Pubmed	Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation.	EPOR IRS2	6.85e-05	3	167	2	9334184
Pubmed	Nuclear-cytoplasmic shuttling of a RING-IBR protein RBCK1 and its functional interaction with nuclear body proteins.	CREBBP PML	6.85e-05	3	167	2	15833741
Pubmed	Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action.	IRS2 GAB1	6.85e-05	3	167	2	15821749
Pubmed	Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC).	CEACAM6 CEACAM1	6.85e-05	3	167	2	31171910
Pubmed	Involvement of the Arp2/3 complex and Scar2 in Golgi polarity in scratch wound models.	ACTR3 WASF2	6.85e-05	3	167	2	12589062
Pubmed	SKAP2, a novel target of HSF4b, associates with NCK2/F-actin at membrane ruffles and regulates actin reorganization in lens cell.	HSF4 SKAP2	6.85e-05	3	167	2	20219016
Pubmed	The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor.	ZMIZ1 ZMIZ2	6.85e-05	3	167	2	17584785
Pubmed	Cooperation of the transcriptional coactivators CBP and p300 with Stat6.	CREBBP STAT6	6.85e-05	3	167	2	10454341
Pubmed	CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production.	CEACAM6 CEACAM1 FCGR2A	8.41e-05	18	167	3	25692415
Pubmed	Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner.	PIAS1 CREBBP PML	9.96e-05	19	167	3	32545337
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	SMC1A RBM26 PIAS1 CREBBP AP1B1 ZMIZ2 PML	1.05e-04	222	167	7	37071664
Pubmed	Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development.	HIF3A ACAN ARNT2	1.17e-04	20	167	3	20495570
Pubmed	Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DMXL2 MYCBP2 MON1B NFAT5 GOLGA8A	1.25e-04	100	167	5	10048485
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MAGI1 PODNL1 DMXL2 CDV3 RNPC3 IQSEC2 RBM26 SIK3 ZMIZ2 DENND4B LPXN SSH2	1.34e-04	689	167	12	36543142
Pubmed	Diverse oligomeric states of CEACAM IgV domains.	CEACAM6 CEACAM1	1.37e-04	4	167	2	26483485
Pubmed	Trans-interaction of nephrin and Neph1/Neph3 induces cell adhesion that associates with decreased tyrosine phosphorylation of nephrin.	NPHS1 KIRREL2	1.37e-04	4	167	2	21306299
Pubmed	Differential localization profile of Fras1/Frem proteins in epithelial basement membranes of newborn and adult mice.	FREM3 FREM1	1.37e-04	4	167	2	18563433
Pubmed	Four carcinoembryonic antigen subfamily members, CEA, NCA, BGP and CGM2, selectively expressed in the normal human colonic epithelium, are integral components of the fuzzy coat.	CEACAM6 CEACAM1	1.37e-04	4	167	2	10436421
Pubmed	Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs.	CEACAM6 CEACAM1	1.37e-04	4	167	2	27748768
Pubmed	Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA.	CEACAM6 CEACAM1	1.37e-04	4	167	2	27748756
Pubmed	Cortactin scaffolds Arp2/3 and WAVE2 at the epithelial zonula adherens.	ACTR3 WASF2	1.37e-04	4	167	2	24469447
Pubmed	Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells.	CEACAM6 CEACAM1	1.37e-04	4	167	2	19077207
Pubmed	Transcription of nephrin-Neph3 gene pair is synergistically activated by WT1 and NF-κB and silenced by DNA methylation.	NPHS1 KIRREL2	1.37e-04	4	167	2	21980157
Pubmed	MAGI-1 Interacts with Nephrin to Maintain Slit Diaphragm Structure through Enhanced Rap1 Activation in Podocytes.	NPHS1 MAGI1	1.37e-04	4	167	2	27707879
Pubmed	Hes6 controls cell proliferation via interaction with cAMP-response element-binding protein-binding protein in the promyelocytic leukemia nuclear body.	CREBBP PML	1.37e-04	4	167	2	18160400
Pubmed	Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24.	CREBBP STAT6	1.37e-04	4	167	2	31554795
Pubmed	Involvement of the Rac1-IRSp53-Wave2-Arp2/3 Signaling Pathway in HIV-1 Gag Particle Release in CD4 T Cells.	ACTR3 WASF2	1.37e-04	4	167	2	26018170
Pubmed	Single-cell analysis reveals specific neuronal transition during mouse corticogenesis.	BCL11B PDZRN3	1.37e-04	4	167	2	38020907
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	KIRREL2 RGS3 STAT6 PCNX2 STARD9 ANKRD34A NOTCH4	1.41e-04	233	167	7	37704626
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DMXL2 RNPC3 SMC1A DHX38 MON1B CDC42BPB JMJD1C UTP4 SSH2 PDZRN3	1.46e-04	493	167	10	15368895
Pubmed	A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis.	DHX38 UTP4 CDH3	1.57e-04	22	167	3	12417987
Pubmed	Deficiency of STING Signaling in Embryonic Cerebral Cortex Leads to Neurogenic Abnormalities and Autistic-Like Behaviors.	STAT6 BCL11B CDH3	1.57e-04	22	167	3	33304758
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NRCAM SPEG DOCK10 TNRC6C STARD9 DENND4B RIPOR1 SIPA1L2 NFAT5	1.66e-04	407	167	9	12693553
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHGA6 PCDHGA3 PCDHB4 PCDHB18P	1.78e-04	58	167	4	30377227
Interaction	YWHAB interactions	MAGI1 EMC1 MYCBP2 RPAP3 SEC24A SPEG IQSEC2 RANBP9 TNS2 SIK3 RGS3 ACTR3 C6orf132 MICALL1 SHROOM1 NF1 UBE2H BAIAP2L1 STARD9 WASF2 HGS ANKRD34A IRS2 PLEKHM3 SSH2 SIPA1L2 SAP130 GAB1	1.27e-08	1014	164	28	int:YWHAB
Interaction	PCDHGA9 interactions	PCDHGA9 PCDHGA5 PCDHGA3 PCDHGA12 ZFHX3 PCDHGA8	2.45e-07	33	164	6	int:PCDHGA9
Interaction	PCDHGA4 interactions	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA12 PCDHGA8	2.95e-07	34	164	6	int:PCDHGA4
Interaction	PCDHGA8 interactions	PCDHGA9 PCDHGA5 PCDHGA8	5.23e-06	5	164	3	int:PCDHGA8
Interaction	YWHAH interactions	MAGI1 EMC1 MYCBP2 SEC24A SPEG IQSEC2 DHX38 TNS2 SIK3 CREBBP C6orf132 TTLL7 MICALL1 SHROOM1 NF1 UBE2H BAIAP2L1 STARD9 WASF2 IRS2 PLEKHM3 SSH2 SIPA1L2 GAB1	1.01e-05	1102	164	24	int:YWHAH
Interaction	TLE3 interactions	SEC24A TPRX2 ZMIZ1 PIAS1 CREBBP MED15 BCL11B RBM12 UBE2H ZMIZ2 INTS4 ZFHX3 SAP130	1.31e-05	376	164	13	int:TLE3
Interaction	PHF21A interactions	MYCBP2 RPAP3 ZMIZ1 JMJD1C LLGL2 ZMIZ2 LPXN ZFHX3 IRS2 PCCB PKN3 PML	2.53e-05	343	164	12	int:PHF21A
Interaction	PCDHGB1 interactions	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA12 CDH3 PKN3	3.90e-05	77	164	6	int:PCDHGB1
Interaction	STAT2 interactions	MYCBP2 CREBBP INSYN2A STAT6 GAA PML	5.20e-05	81	164	6	int:STAT2
Interaction	RYK interactions	PCDHGC4 PCDHGA11 PCDHGA6 PCDHGA5 FAT3 F5 PCDHGA12 WASF2 HGS	6.17e-05	212	164	9	int:RYK
Interaction	YWHAG interactions	MAGI1 MYCBP2 RPAP3 SEC24A SPEG IQSEC2 TNS2 SIK3 PIAS1 C6orf132 TTLL7 MICALL1 SHROOM1 NF1 UBE2H BAIAP2L1 STARD9 WASF2 ANKRD34A IRS2 PLEKHM3 SSH2 SIPA1L2 GAB1	7.46e-05	1248	164	24	int:YWHAG
Cytoband	5q31	MYOT PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHB18P PCDHGA12 PCDHGA8	1.60e-14	115	167	12	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	MYOT PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 SEC24A PCDHGA1 PCDHB4 PCDHB18P SHROOM1 PCDHGA12 PCDHGA8	6.14e-12	298	167	14	chr5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr16q22	DHX38 UTP4 RIPOR1 ZFHX3 HSF4 NFAT5 CDH3	5.27e-06	183	167	7	chr16q22
Cytoband	16q22.1	UTP4 RIPOR1 NFAT5 CDH3	7.22e-04	110	167	4	16q22.1
Cytoband	9q34.11	DYNC2I2 PKN3 CFAP157	9.69e-04	53	167	3	9q34.11
GeneFamily	Clustered protocadherins	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHB4 PCDHB18P PCDHGA12 PCDHGA8	2.15e-13	64	114	11	20
GeneFamily	Zinc fingers MIZ-type	ZMIZ1 PIAS1 ZMIZ2	8.39e-06	7	114	3	85
GeneFamily	Immunoglobulin like domain containing	NPHS1 NRCAM CEACAM6 KIRREL2 CEACAM1 FCGR2A IGSF9B	2.23e-04	193	114	7	594
GeneFamily	Ataxins\|Trinucleotide repeat containing	MAGI1 TNRC6C MED15	5.07e-04	25	114	3	775
GeneFamily	Fibronectin type III domain containing	NPHS1 EPOR NRCAM MID2 ROS1 IGSF9B	5.31e-04	160	114	6	555
GeneFamily	Adenosine receptors\|V-set domain containing	NPHS1 CEACAM6 CEACAM1 SIGLEC7 ACAN IGSF9B	5.86e-04	163	114	6	590
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	DOK6 DOCK10 IRS2 PLEKHM3 SKAP2 GAB1	1.96e-03	206	114	6	682
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CD248 FREM1 ACAN	2.19e-03	41	114	3	1298
GeneFamily	PDZ domain containing	MAGI1 APBA3 RGS3 SIPA1L2 PDZRN3	2.77e-03	152	114	5	1220
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYOT NRCAM SPEG KIRREL2 IGSF9B	3.54e-03	161	114	5	593
GeneFamily	Wiskott-Aldrich Syndrome protein family	WASH6P WASF2	4.46e-03	16	114	2	14
GeneFamily	Cadherin related	FAT3 CDHR4	5.04e-03	17	114	2	24
GeneFamily	WD repeat domain containing	DMXL2 DYNC2I2 DCAF12L2 LLGL2 DCAF12L1 UTP4	6.34e-03	262	114	6	362
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN	LILRA2 IQSEC2 DHX38 STAT6 CROT UBA7 AP1B1 ZFHX3 MUC6 GAA	5.98e-07	200	165	10	M5237
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	DOK6 MYCBP2 SPEG RBM26 PCDHB4 TNRC6C ZMIZ1 SIK3 INSYN2A TTLL7 PTPN5 CREBRF FSIP2 BCL11B ARNT2 ZFHX3 C2CD6 IGSF9B SSH2 HCFC2 GOLGA8A FRMD3	1.85e-06	1106	165	22	M39071
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TNS2 SORCS1 TMEM132C FSIP2 ACAN C2CD6 IGSF9B GOLGA8A	1.26e-07	155	166	8	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PODNL1 NRCAM CD248 CRTAC1 RGS3 TMEM132C PCDHGA12 ACAN	5.28e-07	187	166	8	f1d0fc625e0e7881b3f290742fd7148d995eb71e
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PODNL1 NRCAM CD248 CRTAC1 RGS3 TMEM132C PCDHGA12 ACAN	5.28e-07	187	166	8	02e7246ef5ad41773d14426254e139b156d45c1d
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PODNL1 NRCAM CD248 CRTAC1 RGS3 TMEM132C PCDHGA12 ACAN	5.28e-07	187	166	8	08c73d125e0638c9e9878165bba2442c266c8a48
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EPOR NRCAM CRTAC1 BICD1 CROT NPAP1 NFAT5 MUC6	5.95e-07	190	166	8	078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MGAM NRCAM FAT3 DOCK10 HIF3A TPCN1 PDZRN3 FRMD3	6.44e-07	192	166	8	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM SPEG HIF3A DYSF RGS3 STARD9 IGSF9B PDZRN3	8.12e-07	198	166	8	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	COVID-19-COVID-19_Mild-Myeloid-Neutrophil\|COVID-19_Mild / Disease, condition lineage and cell class	MGAM DYSF F5 CEACAM1 FCGR2A EGR3 IRS2 SIPA1L2	8.44e-07	199	166	8	9f6b6731186ef399f952a75879eba66fd8ed3494
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	MAGI1 F5 FREM1 CARF FRMD3 CDHR4 PEAR1	3.29e-06	168	166	7	1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	MAGI1 F5 FREM1 CARF FRMD3 CDHR4 PEAR1	3.29e-06	168	166	7	69f534de0f9a293047bea03cb1b78551087a8df5
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 CEACAM6 TTLL7 MYO5C LLGL2 GOLGA8A FRMD3	6.20e-06	185	166	7	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNS2 HIF3A SHROOM1 EGR3 PCDHGA12 PKN3 NOTCH4	6.89e-06	188	166	7	a37edd8f9e4a4e336b5acbb0407d3d275975cee8
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MAGI1 CEACAM6 MYO5C LLGL2 BAIAP2L1 ROS1 FHIP1A	6.89e-06	188	166	7	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ADAMTS19 FREM1 TTLL7 BICD1 SORCS1 TMEM132C PDZRN3	6.89e-06	188	166	7	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 HIF3A MYO5C RNF220 ROS1 GOLGA8A FHIP1A	7.38e-06	190	166	7	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	T_cells-CD56_bright_CD16-_NK_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	HIF3A MYRFL INSYN2A TMEM132C ZFHX3 SKAP2 GAB1	8.18e-06	193	166	7	826457e2aafdb61ead8a0a44d8cf9088d310684b
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOK6 ADAMTS19 CD248 COLGALT2 FREM1 TMEM132C PDZRN3	8.18e-06	193	166	7	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	DUSP5 DYSF JMJD1C CEACAM1 SIPA1L2 NOTCH4 PEAR1	8.18e-06	193	166	7	479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOT MYCBP2 PCDHGA5 SMC1A JMJD1C ARHGAP5 IRS2	8.74e-06	195	166	7	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DOK6 TNRC6C TFR2 BCL11B LLGL2 STARD9 GOLGA8A	9.35e-06	197	166	7	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM SPEG HIF3A TTLL7 STARD9 IGSF9B PDZRN3	9.35e-06	197	166	7	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRCAM SPEG HIF3A DYSF STARD9 IGSF9B PDZRN3	9.66e-06	198	166	7	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	COVID_vent-Myeloid\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DMXL2 LILRA2 DYSF F5 FCGR2A SKAP2 GAA	1.03e-05	200	166	7	621af09aae34226902c03edf556562f3ab35a7d8
ToppCell	COVID_vent-Myeloid-Monocytic-CD14+_Monocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DMXL2 LILRA2 DYSF F5 FCGR2A SKAP2 GAA	1.03e-05	200	166	7	e57452b73abb21cb3f645d45523ab93f6bef0243
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPEG C2orf81 GGT7 MICALL1 NPAP1 GOLGA8A	1.27e-05	137	166	6	0c82f815c014d01213d23b466043d6e57186dceb
ToppCell	droplet-Fat-Scat-21m-Hematologic-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGA11 ESRRB DUSP5 MYO5C JHY	2.44e-05	92	166	5	246aebf5f17d50f67a7b48f713ea5043cefefb24
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ADAMTS19 F5 PASD1 RIPOR1 FRMD3	2.56e-05	155	166	6	90e629681a72baacc7981b82883866a487638dbc
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ADAMTS19 F5 PASD1 RIPOR1 FRMD3	2.56e-05	155	166	6	e7f49e2fdaf184fa6b4e685518004e7deff1316d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ADAMTS19 F5 PASD1 RIPOR1 FRMD3	2.56e-05	155	166	6	5a872ca70ae8c30b57f45a6772d7bf565e0c2663
ToppCell	droplet-Fat-Scat-21m-Hematologic\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGA11 ESRRB DUSP5 MYO5C JHY	3.15e-05	97	166	5	440d45ecfc9b66cb61d734118601e745892d51e3
ToppCell	droplet-Fat-Scat-21m-Hematologic-erythroblast\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGA11 ESRRB DUSP5 MYO5C JHY	3.15e-05	97	166	5	6fff45d4c4bbd81a67e1ad12b131cfe6a5ab37e6
ToppCell	367C-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NPHS1 DUSP5 TTLL7 EGR3 TMEM143 GAB1	4.01e-05	168	166	6	80233a13135fd159f5764336a1fe67fba237776b
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MAGI1 UBA7 CARF FRMD3 CDHR4 PEAR1	4.01e-05	168	166	6	c66a61d3ec711796313a2c6d2dc39aedbfc20afd
ToppCell	Control\|World / group, cell type (main and fine annotations)	MAGI1 PGC MYO5C BAIAP2L1 ROS1 FHIP1A	4.01e-05	168	166	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MAGI1 UBA7 CARF FRMD3 CDHR4 PEAR1	4.01e-05	168	166	6	83b4f817d95daa15ae60668e789f97d8a3b2e6dd
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ADAMTS19 COLGALT2 DCAF12L2 F5 RIPOR1	4.29e-05	170	166	6	60bbd738c12e64e483485586c30057304884f5a6
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	MID2 MYO5C AP1B1 HSF4 GOLGA8A FRMD3	4.29e-05	170	166	6	c1f7f1bb8865e954bb499963d82bb51923d5d8d6
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK10 TTLL7 ARHGAP5 BCL11B HSF4 HNRNPLL	4.29e-05	170	166	6	adb625124832b0786a590e8f75b61e7263a1e0d4
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPEG FAT3 TTLL7 ZFHX3 IGSF9B PDZRN3	4.73e-05	173	166	6	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DMXL2 DUSP5 DYSF HSF4 GOLGA8A CDH3	5.20e-05	176	166	6	27e5115fae5f0f63b333bc99fbf6a6d4c9182c46
ToppCell	PCW_13-14-Neuronal-Neuronal_SCP\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYOT TTLL7 SORCS1 IGSF9B FAM181B FRMD3	5.37e-05	177	166	6	621dd82f1393c961d4dd7a615aa52c9df9e36336
ToppCell	PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NRCAM DOCK10 TTLL7 SORCS1 IGSF9B FAM181B	5.37e-05	177	166	6	59726bfd98f656fdcedf448a7e2e76a9bfad8285
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODNL1 GGT7 PTPN5 BCL11B ARNT2 LPXN	5.54e-05	178	166	6	888add8935ef3aef9b6693c5698e9d1842e66337
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODNL1 GGT7 PTPN5 BCL11B ARNT2 LPXN	5.54e-05	178	166	6	43eda32af2e5e28a92421612d0a4c21e5427a772
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Dcn\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NPHS1 C3orf20 ROS1 MUC6	5.65e-05	56	166	4	821d5939c7c8d3ebbb2e0c64d0197f639f02278a
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Dcn-Excitatory_Neuron.Slc17a7.Dcn-Pou3f1_(Anterior_Subiculum,_proximal_to_CA1)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NPHS1 C3orf20 ROS1 MUC6	5.65e-05	56	166	4	a762127a14327e8ab55a3e25ec26a84cc3210693
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM FAT3 FREM1 TMEM132C PDZRN3 FRMD3	5.89e-05	180	166	6	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	SPEG FAT3 TTLL7 ZFHX3 IGSF9B PDZRN3	5.89e-05	180	166	6	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM FAT3 FREM1 TMEM132C PDZRN3 FRMD3	5.89e-05	180	166	6	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM FAT3 FREM1 TMEM132C PDZRN3 FRMD3	6.08e-05	181	166	6	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOK6 FAT3 FREM1 TMEM132C C2CD6 PDZRN3	6.08e-05	181	166	6	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NRCAM MYO5C LLGL2 CDH3 FHIP1A FRMD3	6.46e-05	183	166	6	c5b10571599dc26476170b54b53f09c23e6b3117
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM NRCAM FAT3 FREM1 SORCS1 ROS1	6.65e-05	184	166	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 CEACAM6 TTLL7 MYO5C LLGL2 GAB1	6.65e-05	184	166	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM NRCAM FAT3 FREM1 SORCS1 ROS1	6.65e-05	184	166	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM NRCAM FAT3 FREM1 SORCS1 ROS1	6.65e-05	184	166	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 CEACAM6 TTLL7 MYO5C LLGL2 GAB1	6.65e-05	184	166	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	MAGI1 CEACAM6 MYO5C BAIAP2L1 ROS1 FHIP1A	6.86e-05	185	166	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	DMXL2 MYCBP2 DOCK10 NUP155 DENND4B NFAT5	6.86e-05	185	166	6	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DUSP5 CDC42BPB JMJD1C CEACAM1 SIPA1L2 NOTCH4	6.86e-05	185	166	6	673308ca0514a4d3629d61fe91e9d8fb31b72166
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DUSP5 HIF3A SHROOM1 EGR3 PKN3 NOTCH4	6.86e-05	185	166	6	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 CRTAC1 MYO5C LLGL2 ROS1 FHIP1A	7.06e-05	186	166	6	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ADAMTS19 KIRREL2 DCAF12L2 F5 RIPOR1	7.06e-05	186	166	6	1094c7140131454b2583200e1c01e81ccab3db23
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MGAM DMXL2 DYSF F5 FCGR2A IRS2	7.06e-05	186	166	6	05c40bac5c0ade8b67b7c2112739466e02dbf22b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 FREM1 BAIAP2L1 ARNT2 SIPA1L2 NFAT5	7.06e-05	186	166	6	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEACAM1 TTLL7 DCAF12L1 FAM181B NOTCH4 FRMD3	7.06e-05	186	166	6	4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	MAGI1 TTLL7 MYO5C LLGL2 GOLGA8A FHIP1A	7.06e-05	186	166	6	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO5C RNF220 LLGL2 ROS1 CDH3 FHIP1A	7.06e-05	186	166	6	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	Adult-Endothelial-endothelial_cell_of_artery\|Adult / Lineage, Cell type, age group and donor	DUSP5 HIF3A EGR3 ARNT2 PKN3 NOTCH4	7.06e-05	186	166	6	2d1c4ea2e401db89971582ee54618a8b0c81b8ac
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	MYO5C RNF220 LLGL2 ROS1 CDH3 FHIP1A	7.28e-05	187	166	6	db2974e2e87ac9f1c2407a371d5ed89af09fc9b7
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 CRTAC1 HIF3A PGC ROS1 FHIP1A	7.28e-05	187	166	6	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	MAGI1 RGS3 SHROOM1 SIPA1L2 PKN3 NOTCH4	7.28e-05	187	166	6	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 TTLL7 MYO5C LLGL2 GOLGA8A FHIP1A	7.28e-05	187	166	6	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|368C / Donor, Lineage, Cell class and subclass (all cells)	CEACAM6 CRTAC1 C6orf132 UBE2H ROS1 GOLGA8A	7.28e-05	187	166	6	b827d9da7032bf051756ddf88352af922eb0f87b
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	CEACAM6 CRTAC1 C6orf132 UBE2H ROS1 GOLGA8A	7.28e-05	187	166	6	61c00604dda8b36a5c3eea6554e5601aa1b884f7
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	DOCK10 SIK3 JMJD1C NF1 UBE2H NFAT5	7.49e-05	188	166	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 F5 BICD1 ARNT2 IGSF9B SIPA1L2	7.49e-05	188	166	6	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 ADAMTS19 KIRREL2 F5 RIPOR1 FRMD3	7.49e-05	188	166	6	9db778c1d9e622a68337212296e3a1ed8f771fa5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 FREM1 BAIAP2L1 ARNT2 SIPA1L2 NFAT5	7.49e-05	188	166	6	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	AT1-AT2_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	CEACAM6 TTLL7 MYO5C LLGL2 GOLGA8A FRMD3	7.49e-05	188	166	6	be710bc957118cf426dd71c2d57e6f1b41c9a467
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPHS1 F5 BICD1 ARNT2 IGSF9B SIPA1L2	7.49e-05	188	166	6	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNPC3 ESRRB FREM1 MYO5C LLGL2 ARNT2	7.72e-05	189	166	6	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NRCAM MYO5C LLGL2 CDH3 FHIP1A FRMD3	7.72e-05	189	166	6	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RNPC3 ESRRB FREM1 MYO5C LLGL2 ARNT2	7.72e-05	189	166	6	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 NRCAM ESRRB SIK3 FREM1 NFAT5	7.72e-05	189	166	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RNPC3 ESRRB MYO5C UBE2H FHIP1A GAB1	7.72e-05	189	166	6	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESRRB TTLL7 PCDHB18P GAB1 NOTCH4 PEAR1	7.72e-05	189	166	6	ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRCAM FAT3 FREM1 TMEM132C PDZRN3 FRMD3	7.72e-05	189	166	6	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	MAGI1 CEACAM6 TTLL7 MYO5C LLGL2 FRMD3	7.72e-05	189	166	6	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	facs-MAT-Fat-18m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGI1 DYSF CEACAM1 TTLL7 FAM181B NOTCH4	7.94e-05	190	166	6	34e56c5e7ea6a8f227dbaefe73cbb8818d18b523
ToppCell	facs-MAT-Fat-18m-Endothelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGI1 DYSF CEACAM1 TTLL7 FAM181B NOTCH4	7.94e-05	190	166	6	14cdb660ad3aabcf49572173e7628d8b99dcbe6f
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NRCAM CRTAC1 HIF3A TMEM132C ACAN IGSF9B	7.94e-05	190	166	6	6c7e1086c0a274cd5527c3104106e372811c9905
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DUSP5 HIF3A SHROOM1 EGR3 PKN3 NOTCH4	7.94e-05	190	166	6	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	facs-MAT-Fat-18m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGI1 DYSF CEACAM1 TTLL7 FAM181B NOTCH4	7.94e-05	190	166	6	9aaa48f3aad813c87a45efdbb67d255c94f6e6a4
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	NRCAM MYO5C LLGL2 CDH3 FHIP1A FRMD3	8.18e-05	191	166	6	05731ece7867659c662f952812805f947032fe10
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-tip_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MAGI1 PCDHGA6 PCDHGA1 TNS2 PTPN5 NOTCH4	8.18e-05	191	166	6	cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0
ToppCell	COVID-19-kidney-Stressed_EC\|kidney / Disease (COVID-19 only), tissue and cell type	DUSP5 DYSF CEACAM1 SIPA1L2 NOTCH4 PEAR1	8.18e-05	191	166	6	d35aa842b813ea0eff7362abc894cca4e86b2fb2
ToppCell	PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CEACAM6 MYO5C BAIAP2L1 CDH3 FHIP1A FRMD3	8.18e-05	191	166	6	63aa671837b79d2feb7ed1e67712cc01caf72bef
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 MYO5C LLGL2 ROS1 GOLGA8A FHIP1A	8.18e-05	191	166	6	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DUSP5 RANBP9 CEACAM6 C6orf132 CEACAM1 ARHGAP5	8.18e-05	191	166	6	fbd8d337b4444fba8527a614e4a8bfb516ce0f66
Drug	montmorillonite	MGAM PCDHGC4 PCDHGA11 PCDHGA3 PCDHGA12 PCDHGA8	3.99e-07	40	164	6	CID000517273
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A	IQSEC2 UBA7 NF1 SIGLEC7 IRS2 HCFC2 NFAT5 MUC6 PML	6.25e-06	179	164	9	2656_UP
Drug	CID9959010	PCDHGC4 PCDHGA11 PCDHGA3 PCDHGA12 PCDHGA8	8.62e-06	39	164	5	CID009959010
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	SEC24A CDC42BPB CREBBP RGS3 MICALL1 NF1 ARNT2 HCFC2 AP3D1	1.15e-05	193	164	9	6981_DN
Drug	Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A	PODNL1 EMC1 IQSEC2 CEACAM6 DYSF TPCN1 ZMIZ2 IRS2 PML	1.24e-05	195	164	9	4399_DN
Drug	GSK-3 Inhibitor IX; Down 200; 0.5uM; MCF7; HT_HG-U133A	EPOR DYSF RGS3 BICD1 NF1 EGR3 ZMIZ2 IRS2 JHY	1.30e-05	196	164	9	7044_DN
Drug	Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	EPOR EMC1 IQSEC2 DYSF NF1 LPXN IRS2 JHY PML	1.30e-05	196	164	9	3351_DN
Drug	Rolitetracycline [751-97-3]; Down 200; 7.6uM; HL60; HT_HG-U133A	DOK1 LILRA2 SMC1A NPEPL1 CEACAM1 TFR2 CROT NF1 ZMIZ2	1.35e-05	197	164	9	3031_DN
Drug	Trichlormethiazide [133-67-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A	EMC1 SMC1A IQSEC2 DYSF BICD1 RBM12 LPXN ZFHX3 PML	1.35e-05	197	164	9	3337_DN
Drug	Cefotetan [69712-56-7]; Down 200; 7uM; MCF7; HT_HG-U133A	SMC1A POM121L2 DYSF BICD1 BCL11B CARF RIPOR1 JHY PML	1.41e-05	198	164	9	4116_DN
Drug	AC1L3M0Q	MGAM RNPC3 GAA	4.24e-05	10	164	3	CID000118008
Drug	AC1L1UVI	PCDHGC4 PCDHGA11 PCDHGA3 PCDHGA12 PCDHGA8	4.74e-05	55	164	5	CID000061263
Drug	Miglitol	MGAM GAA	5.16e-05	2	164	2	DB00491
Drug	FG5P	MGAM RNPC3 GAA	5.80e-05	11	164	3	CID000127486
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A	EPOR CDV3 MID2 SMC1A NPEPL1 ZMIZ2 ZFHX3 PML	7.86e-05	192	164	8	1792_UP
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A	EPOR CEACAM6 APBA3 BICD1 PCNX2 NF1 ZFHX3 AP3D1	8.45e-05	194	164	8	2824_DN
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A	MAGI1 EPOR PODNL1 SMC1A UBA7 CARF LPXN PML	8.45e-05	194	164	8	1628_UP
Drug	Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; HL60; HT_HG-U133A	NPHS1 NRCAM APBA3 CRTAC1 PCNX2 EGR3 ACAN MUC6	8.76e-05	195	164	8	6159_UP
Drug	Ethionamide [536-33-4]; Down 200; 24uM; MCF7; HT_HG-U133A	EPOR CEACAM6 MED15 BCL11B NF1 ZMIZ2 CARF PML	8.76e-05	195	164	8	4418_DN
Drug	Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A	EPOR IQSEC2 F5 BICD1 NF1 ACAN RIPOR1 IRS2	8.76e-05	195	164	8	7468_UP
Drug	PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A	DOK1 IQSEC2 POM121L2 TFR2 ZMIZ2 CARF JHY PML	9.08e-05	196	164	8	3732_UP
Drug	Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A	DOK1 DMXL2 CEACAM6 PCNX2 ARHGAP5 ZMIZ2 MAGEC1 PML	9.08e-05	196	164	8	6781_UP
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; HL60; HT_HG-U133A	DOK1 DMXL2 LILRA2 IQSEC2 RGS3 MED15 MUC6 GAB1	9.08e-05	196	164	8	3049_DN
Drug	Dydrogesterone [152-62-5]; Up 200; 12.8uM; HL60; HT_HG-U133A	LILRA2 HIF3A CREBBP RGS3 TTLL7 SIGLEC7 RIPOR1 PML	9.41e-05	197	164	8	2156_UP
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	EPOR SMC1A DOCK10 TNS2 NF1 HSF4 NFAT5 PML	9.41e-05	197	164	8	3894_DN
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; HL60; HG-U133A	LILRA2 CDV3 CD248 NPEPL1 BICD1 NF1 ACAN PML	9.41e-05	197	164	8	1406_DN
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	EPOR PODNL1 SMC1A TNS2 MICALL1 NF1 ZMIZ2 PML	9.41e-05	197	164	8	3877_DN
Drug	Evoxine [522-11-2]; Up 200; 11.6uM; PC3; HT_HG-U133A	DOK1 CD248 PCDHGA1 F5 STAT6 NF1 ARNT2 GAB1	9.41e-05	197	164	8	3681_UP
Drug	Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A	MGAM RBM26 POM121L2 TFR2 MED15 ZMIZ2 RIPOR1 PML	9.41e-05	197	164	8	3209_UP
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A	DOK1 DUSP5 IQSEC2 DOCK10 NF1 EGR3 HSF4 GAB1	9.74e-05	198	164	8	3897_DN
Drug	cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Up 200; 100uM; PC3; HG-U133A	EPOR SPEG CLASRP BICD1 CROT NF1 ACAN AP3D1	9.74e-05	198	164	8	664_UP
Drug	Nadide [53-84-9]; Down 200; 6uM; HL60; HT_HG-U133A	PODNL1 POM121L2 F5 RGS3 CROT NF1 ZMIZ2 GAA	9.74e-05	198	164	8	2529_DN
Drug	U-62066 [87151-85-7]; Down 200; 1uM; MCF7; HT_HG-U133A	EPOR SMC1A MICALL1 NF1 ZMIZ2 IRS2 HSF4 PML	9.74e-05	198	164	8	3901_DN
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	EPOR MICALL1 NF1 ZMIZ2 RIPOR1 IRS2 MUC6 JHY	9.74e-05	198	164	8	7349_UP
Drug	Naloxone hydrochloride [357-08-4]; Up 200; 11uM; HL60; HG-U133A	EPOR DOCK10 APBA3 PGC TFR2 MICALL1 EGR3 ACAN	9.74e-05	198	164	8	2006_UP
Drug	methyl 1'-epiacarviosin	MGAM RNPC3 GAA	9.95e-05	13	164	3	CID000197426
Drug	isoacarbose	MGAM RNPC3 GAA	9.95e-05	13	164	3	CID000449165
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HG-U133A	MID2 CLASRP TPCN1 MICALL1 ARHGAP5 UBE2H DENND4B PML	1.01e-04	199	164	8	1890_DN
Drug	rotenone; Down 200; 1uM; PC3; HT_HG-U133A	DOCK10 HIF3A NPEPL1 TFR2 BCL11B NF1 ACAN PML	1.01e-04	199	164	8	5920_DN
Drug	Artemisinin [63968-64-9]; Down 200; 14.2uM; HL60; HG-U133A	PODNL1 LILRA2 MID2 PCNX2 RNF220 SIGLEC7 IRS2 AP3D1	1.01e-04	199	164	8	1714_DN
Drug	Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; HL60; HT_HG-U133A	EPOR IQSEC2 POM121L2 NPEPL1 NF1 SIGLEC7 GAB1 PML	1.01e-04	199	164	8	3128_DN
Drug	AC1NFC6P	PCDHGC4 PCDHGA11 PCDHGA3 HIF3A PCDHGA12 HCFC2 PCDHGA8	1.01e-04	148	164	7	CID000004587
Drug	Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A	NPHS1 PCDHGA1 POM121L2 BICD1 SIGLEC7 IRS2 JHY PML	1.04e-04	200	164	8	7329_UP
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; HL60; HT_HG-U133A	EMC1 APBA3 MICALL1 PCNX2 CROT ZMIZ2 MUC6 PML	1.04e-04	200	164	8	3008_DN
Drug	Diazoxide [364-98-7]; Up 200; 17.4uM; HL60; HG-U133A	EPOR MGAM POM121L2 PGC CEACAM1 AP1B1 NFAT5 AP3D1	1.04e-04	200	164	8	1368_UP
Drug	ss,ss-carotene	PCDHGC4 PCDHGA11 PCDHGA3 UBA7 PCDHGA12 CARF ROS1 PCDHGA8	1.08e-04	201	164	8	CID000000573
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHGA12 PCDHGA8	2.02e-10	71	162	9	EFO_0007878, EFO_0007979
Disease	mental development measurement	PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHGA8	4.05e-09	25	162	6	EFO_0008230
Disease	Sarcosine measurement	PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 PCDHGA8	1.46e-07	23	162	5	EFO_0021668
Disease	mean platelet volume	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 DOCK10 ZMIZ1 SIK3 CDC42BPB JMJD1C RGS3 AP1B1 PCDHGA12 ZMIZ2 INTS4 RIPOR1 IRS2 PCDHGA8 PEAR1	2.10e-07	1020	162	21	EFO_0004584
Disease	diet measurement, HOMA-B	MAGI1 FAT3 PCNX2 NFAT5	3.18e-06	19	162	4	EFO_0004469, EFO_0008111
Disease	lymphocyte count	PCDHGC4 PCDHGA11 PCDHGA9 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA1 DOCK10 HIF3A ZMIZ1 JMJD1C TFR2 BCL11B UBE2H BAIAP2L1 PCDHGA12 RIPOR1 SSH2 SKAP2 HNRNPLL PCDHGA8 AP3D1	1.79e-05	1464	162	22	EFO_0004587
Disease	FEV/FEC ratio	MGAM PCDHGA5 SPEG PCDHGA1 MYRFL JMJD1C MED15 LLGL2 FCGR2A EGR3 ACAN RIPOR1 ZFHX3 SSH2 SKAP2 AP3D1 PDZRN3 CDHR4 PML	4.74e-05	1228	162	19	EFO_0004713
Disease	orofacial cleft, sex interaction measurement	NRCAM BCL11B NF1 ZFHX3 NOTCH4	1.14e-04	86	162	5	EFO_0008343, MONDO_0000358
Disease	response to clopidogrel, cardiovascular event measurement	CRTAC1 DYSF FREM1	2.65e-04	23	162	3	EFO_0006919, GO_1903493
Disease	mucinous adenocarcinoma (is_marker_for)	ZFHX3 MUC6	2.96e-04	5	162	2	DOID:3030 (is_marker_for)
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	DMXL2 DYSF JMJD1C TTLL7 UBA7 ZMIZ2 IGSF9B FHIP1A CDHR4	3.73e-04	398	162	9	EFO_0003756, EFO_0003888, EFO_0004337
Disease	very low density lipoprotein cholesterol measurement	DHX38 BUD13 CRTAC1 HIF3A SIK3 JMJD1C PCCB	6.08e-04	260	162	7	EFO_0008317
Disease	neuronal pentraxin-2 measurement	BUD13 F5	6.18e-04	7	162	2	EFO_0801834
Disease	severe acute respiratory syndrome, COVID-19	MAGI1 RBM26 MICALL1 MED15 TMEM132C ARNT2 ZFHX3 SIPA1L2 GOLGA8A	8.53e-04	447	162	9	EFO_0000694, MONDO_0100096
Disease	bitter alcoholic beverage consumption measurement	MGAM STAT6 NF1 ZFHX3 IGSF9B	8.56e-04	133	162	5	EFO_0010092
Disease	metabolic syndrome	BUD13 CRTAC1 SIK3 JMJD1C NFAT5 PCCB	8.57e-04	200	162	6	EFO_0000195
Disease	Malignant neoplasm of breast	ADAMTS19 EPOR NRCAM COLGALT2 ZMIZ1 SIK3 DYSF CLASRP SORCS1 MICALL1 LLGL2 NF1 ANKRD34A GAB1 NOTCH4	8.85e-04	1074	162	15	C0006142
Disease	thalamus volume	FAT3 BICD1 BCL11B NFAT5	1.25e-03	85	162	4	EFO_0006935
Disease	beta-nerve growth factor measurement	MON1B F5 NOTCH4	1.59e-03	42	162	3	EFO_0008035
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	BUD13 SIK3	1.59e-03	11	162	2	OBA_2045170
Disease	Cystic Fibrosis	CLCA4 FCGR2A	1.59e-03	11	162	2	C0010674
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	DHX38 CRTAC1 HIF3A SIK3 RBM12 PCCB	1.71e-03	229	162	6	EFO_0004639, EFO_0008317
Disease	platelet measurement	DOK6 DOCK10 ZMIZ1 JMJD1C MICALL1 IRS2 PEAR1	1.84e-03	315	162	7	EFO_0005036
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	CRTAC1 SIK3 JMJD1C PCCB	1.89e-03	95	162	4	EFO_0004529, EFO_0008317, EFO_0008596
Disease	beta-endorphin measurement	BUD13 SIK3	1.91e-03	12	162	2	EFO_0008034
Disease	level of Diacylglycerol (18:1_18:2) in blood serum	BUD13 SIK3	1.91e-03	12	162	2	OBA_2045171
Disease	focal segmental glomerulosclerosis (biomarker_via_orthology)	PIAS1 ACTR3	1.91e-03	12	162	2	DOID:1312 (biomarker_via_orthology)
Disease	dickkopf‐related protein 1 measurement	JMJD1C PEAR1	1.91e-03	12	162	2	EFO_0010620
Disease	chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement	CRTAC1 SIK3 JMJD1C PCCB	1.96e-03	96	162	4	EFO_0004530, EFO_0008317, EFO_0008596
Disease	sterol measurement	BUD13 SIK3	2.25e-03	13	162	2	EFO_0010231
Disease	Adenoid Cystic Carcinoma	MAGI1 SMC1A CREBBP JMJD1C	2.28e-03	100	162	4	C0010606
Disease	triglycerides to total lipids in medium LDL percentage	SIK3 JMJD1C PCCB	2.64e-03	50	162	3	EFO_0022334
Disease	cholesteryl esters to total lipids in IDL percentage	SIK3 JMJD1C PCCB	2.64e-03	50	162	3	EFO_0022247
Disease	triglycerides to total lipids in large LDL percentage	SIK3 JMJD1C PCCB	2.79e-03	51	162	3	EFO_0022331
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	CRTAC1 SIK3 JMJD1C PCCB	2.82e-03	106	162	4	EFO_0008317, EFO_0008596
Disease	Drugs used in diabetes use measurement	MYCBP2 ZMIZ1 JMJD1C NF1 ZFHX3 NFAT5	2.93e-03	255	162	6	EFO_0009924
Disease	thrombosis (is_implicated_in)	F5 FCGR2A	3.00e-03	15	162	2	DOID:0060903 (is_implicated_in)
Disease	free cholesterol to total lipids in small LDL percentage	SIK3 JMJD1C PCCB	3.11e-03	53	162	3	EFO_0022286
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement	CRTAC1 SIK3 JMJD1C PCCB	3.11e-03	109	162	4	EFO_0004639, EFO_0008317, EFO_0008596
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	CRTAC1 SIK3 JMJD1C PCCB	3.22e-03	110	162	4	EFO_0008317, EFO_0008596, EFO_0010351
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	CRTAC1 SIK3 JMJD1C PCCB	3.22e-03	110	162	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	CRTAC1 SIK3 JMJD1C PCCB	3.22e-03	110	162	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	sexual dimorphism measurement	MGAM CD248 BUD13 POM121L2 COLGALT2 ZMIZ1 SIK3 DYSF JMJD1C GGT7 NF1 ACAN ZFHX3 AP3D1	3.23e-03	1106	162	14	EFO_0021796
Disease	IGFBP-3 measurement	CREBBP PKN3 NOTCH4	3.28e-03	54	162	3	EFO_0004626
Disease	level of triacylglycerol (56:6) in blood serum	BUD13 SIK3	3.42e-03	16	162	2	OBA_2020007
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	F5 JMJD1C	3.42e-03	16	162	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	inflammatory bowel disease	HIF3A ZMIZ1 F5 BCL11B FCGR2A LPXN SKAP2 NOTCH4	3.49e-03	449	162	8	EFO_0003767
Disease	triglycerides in very large VLDL measurement	SIK3 JMJD1C PCCB	3.64e-03	56	162	3	EFO_0022325
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	SIK3 JMJD1C PCCB	3.64e-03	56	162	3	EFO_0022316
Disease	proprotein convertase subtilisin/kexin type 7 measurement	BUD13 SIK3	3.86e-03	17	162	2	EFO_0008270
Disease	muscular dystrophy (is_implicated_in)	MYOT DYSF	3.86e-03	17	162	2	DOID:9884 (is_implicated_in)
Disease	neutrophil count	MAGI1 MYCBP2 IQSEC2 ZMIZ1 SIK3 PGC CREBBP JMJD1C BCL11B BAIAP2L1 ANKRD34A SSH2 AP3D1 PKN3 NOTCH4 PEAR1	4.00e-03	1382	162	16	EFO_0004833
Disease	triglycerides in VLDL measurement	SIK3 JMJD1C PCCB	4.22e-03	59	162	3	EFO_0022326
Disease	triglycerides to total lipids in small LDL percentage	SIK3 JMJD1C PCCB	4.22e-03	59	162	3	EFO_0022337
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	SIK3 JMJD1C PCCB	4.22e-03	59	162	3	EFO_0022260
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	NRCAM CRTAC1 SIK3 JMJD1C PCCB CDH3	4.31e-03	276	162	6	EFO_0004612, EFO_0020943
Disease	total lipids in VLDL measurement	SIK3 JMJD1C PCCB	4.42e-03	60	162	3	EFO_0022314
Disease	cholesterol to total lipids in IDL percentage	SIK3 JMJD1C PCCB	4.42e-03	60	162	3	EFO_0022233
Disease	sphingomyelin measurement	ESRRB BUD13 TNRC6C SIK3 JMJD1C FRMD3	4.46e-03	278	162	6	EFO_0010118
Disease	triglycerides in small VLDL measurement	SIK3 JMJD1C PCCB	4.63e-03	61	162	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	SIK3 JMJD1C PCCB	4.63e-03	61	162	3	EFO_0022274
Disease	triglycerides in small HDL measurement	SIK3 JMJD1C PCCB	4.85e-03	62	162	3	EFO_0022158
Disease	phospholipids in large VLDL measurement	SIK3 JMJD1C PCCB	4.85e-03	62	162	3	EFO_0022169
Disease	total lipids in chylomicrons and extremely large VLDL measurement	SIK3 JMJD1C PCCB	4.85e-03	62	162	3	EFO_0022306
Disease	total lipids in very large VLDL measurement	SIK3 JMJD1C PCCB	4.85e-03	62	162	3	EFO_0022313
Disease	phospholipids in very large VLDL measurement	SIK3 JMJD1C PCCB	4.85e-03	62	162	3	EFO_0022299
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	CRTAC1 SIK3 JMJD1C NFAT5 PCCB	5.04e-03	200	162	5	EFO_0004611, EFO_0020945
Disease	triglycerides to total lipids in IDL percentage	SIK3 JMJD1C PCCB	5.07e-03	63	162	3	EFO_0022329
Disease	free cholesterol to total lipids in medium LDL percentage	SIK3 JMJD1C PCCB	5.07e-03	63	162	3	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	SIK3 JMJD1C PCCB	5.07e-03	63	162	3	EFO_0022292
Disease	serum IgE measurement	STAT6 TMEM132C SIPA1L2	5.30e-03	64	162	3	EFO_0004579

Protein segments in the cluster

Peptide	Gene	Start	Entry
SLPSPCNYLNPLDSA	C21orf140	171	B9A014
SPDLAPNVTYSLPRT	BUD13	271	Q9BRD0
SESPSPEDIPDYLLQ	ELL3	276	Q9HB65
YLQNLLRVPPDPTST	BICD1	876	Q96G01
YPDSLFSVKQNPLPS	CREBRF	156	Q8IUR6
QIPVIAANYPDLPSA	CD248	481	Q9HCU0
PTDDDKNIYLTLPPN	FCGR2A	296	P12318
AQSPETLASYPAPQE	APBA3	191	O96018
PTLEALYRQDPESLP	CREBBP	1096	Q92793
PPLVTLLSAEPELQY	AP1B1	286	Q10567
SPTLPQYHPTQLLEL	DMXL2	1341	Q8TDJ6
PPEIYSDTQFPSLQS	CDV3	186	Q9UKY7
SYTPTPTLELLNVQP	CDHR4	46	A6H8M9
SLLPQLSDITPYQPG	CFAP157	446	Q5JU67
TRQYLNSPPSPGVED	ANKRD34A	156	Q69YU3
PEEEQLPPESSYSLL	AP3D1	911	O14617
LSSYDLSQVPVPNLP	ARNT2	456	Q9HBZ2
QSSVKPLPINPDDLY	RBM12	291	Q9NTZ6
TDLPPNLYPTVGLQT	RANBP9	306	Q96S59
DPLENNYTPVSSVPS	RBM26	226	Q5T8P6
TYSPSLKELDPNQPL	PDZRN3	821	Q9UPQ7
TAPTDPNYIILAPLN	RGS3	461	P49796
EYTIPSDPLPENQSS	ADAMTS19	896	Q8TE59
QLYPESIVPIPSSNE	INTS4	261	Q96HW7
NSTRPPSEEPDYQLL	INSYN2A	211	Q6ZSG2
TPELVAYPLPQASSS	HNRNPLL	311	Q8WVV9
NDNTPEILYPALPTD	PCDHGA5	556	Q9Y5G8
NDNAPEILYPALPTD	PCDHGA8	556	Q9Y5G5
QNDNAPEILYPALPT	PCDHGA11	556	Q9Y5H2
NDNAPEILYPALPTD	PCDHGA12	556	O60330
LTSPDPDDPLSSYIN	PTPN5	341	P54829
PYLPLTEAAPSQAQA	PCDHB18P	616	Q96TA0
SNPYLLSLPSDPLEL	LILRA2	401	Q8N149
QLPQFTSPELEAPYS	MON1B	426	Q7L1V2
SYEQQLELPCPDPST	MUC6	2401	Q6W4X9
SPQLPPTQEEVSYSR	NPHS1	1146	O60500
NDNAPEILYPALPTD	PCDHGA6	556	Q9Y5G7
YLDTEKPPAPSQVQL	HCFC2	351	Q9Y5Z7
QIPQSSPESDDTLYP	MAGEC1	36	O60732
SPESDDTLYPLQSPQ	MAGEC1	41	O60732
TDPSQKFPQYLPLSA	MAGI1	281	Q96QZ7
TDSSLENLPLAPLYP	JHY	151	Q6NUN7
ENLPLAPLYPSQETS	JHY	156	Q6NUN7
SEAQQPEPLRSLVPY	LLGL2	261	Q6P1M3
AEPPRILTPANTLYQ	NRCAM	451	Q92823
PPTASALDYPSENLA	KCNK4	331	Q9NYG8
ADSSSATLPPPYQLI	GAB1	151	Q13480
YPELPKPSISSNNSN	CEACAM6	141	P40199
ILDPAISGNETQPYP	MGAM	2211	O43451
LPLYLDDTVPQQSPE	IQSEC2	516	Q5JU85
TLSNSVVNEPPRSYP	JMJD1C	1096	Q15652
SYSVEQLQPAPPGLT	KIAA1614	1026	Q5VZ46
QLQPRYTSPDESPAV	CARF	566	Q8N187
PNSLAIYQLPTLDPL	DCAF12L2	171	Q5VW00
SVQPPSQYDIPRLAA	DYNC2I2	96	Q96EX3
ATPLLQRNPYSSPDI	C2CD6	26	Q53TS8
TEPSQSVPLYNTLLP	FSIP2	4451	Q5CZC0
VDLPYIPAENSPTRQ	DDX42	86	Q86XP3
QYSLLKSVQPDPASP	PCNX2	881	A6NKB5
INDSQAAPAPLLPVY	GGT7	451	Q9UJ14
NDNAPEILYPALPTD	PCDHGA9	556	Q9Y5G4
LSTLNPNPTDSCPLY	NPEPL1	56	Q8NDH3
SENPYATIRDLPSLP	PEAR1	921	Q5VY43
DPPSPNIDYISIQLD	FREM1	251	Q5H8C1
LELSVPADYPAQSPL	MED15	721	Q96RN5
LQRQLPDTPPYSASD	MYRFL	46	Q96LU7
LQDSDEYSNPAPLPL	LPXN	16	O60711
AQPSPTASLESKPYN	MICALL1	411	Q8N3F8
LNEPLSPLYPAAADS	FAM181B	346	A6NEQ2
RNLEAPYIPDVSSPS	CDC42BPB	351	Q9Y5S2
PSDLLYGLEQAPPNT	PCDHGC4	806	Q9Y5F7
LLPPSPVLDSSKQYQ	PLEKHM3	346	Q6ZWE6
VLYISPPPEDLLDNS	NFAT5	141	O94916
LPDPLYSLPTDNTYL	NUP155	201	O75694
QDKVSLPNYPAIPSD	ACAN	101	P16112
LPNYPAIPSDATLEV	ACAN	106	P16112
AQPLQPSSPVAYDII	PASD1	356	Q8IV76
NYLPLSSQDPAPVRE	PCCB	276	P05166
TNAQVTYSLLPPQDP	PCDHB4	481	Q9Y5E5
NDNAPEILYPALPTD	PCDHGA3	556	Q9Y5H0
SLSNNQLSYLPPSLP	PODNL1	201	Q6PEZ8
PVPQPSSASLDEYTL	IRS2	586	Q9Y4H2
LTLPSVDYIPQDSPT	C6orf132	546	Q5T0Z8
VYNPSASLLPTPVDD	FRMD3	446	A2A2Y4
LLTEPPLNTPENREY	ACTR3	111	P61158
EQNYPTPDPLLLTKE	FHIP1A	771	Q05DH4
LPPAALIPSENVYSQ	BCL11B	696	Q9C0K0
LSENSSVVIPPPDYL	BAIAP2L1	426	Q9UHR4
ASQEYNIPIATSLPP	DOCK10	801	Q96BY6
NIPIATSLPPNYLSF	DOCK10	806	Q96BY6
QELLDSPPALYAEPL	DOK1	286	Q99704
PSYAPEQSEEAQQPL	DOK6	301	Q6PKX4
YPELPKPSISSNNSN	CEACAM1	141	P13688
PDNLYPEEIPSALNL	EGR3	21	Q06889
LLQYDLDSPLQEDPP	C3orf20	756	Q8ND61
YEALPPSQPVSLAST	FAT3	4431	Q8TDW7
SLLSLPQEPYSFSEP	GAA	676	P10253
QDPYFIQSPLPETNL	HSF4	236	Q9ULV5
SPYDNLLLCQPVSSP	DENND4B	376	O75064
SNPYENSLIPAAEPL	EPOR	486	P19235
LSLQYPPEVTLSASP	KIRREL2	221	Q6UWL6
PSLDPYLVASPQAST	C2orf81	241	A6NN90
PNSLAIYQLPSLDPL	DCAF12L1	171	Q5VU92
SVLPPDYDSNPTQLN	CRTAC1	41	Q9NQ79
PTEQSREENLIPYSP	EMC1	886	Q8N766
SESSPYLSLQISPPA	ESRRB	191	O95718
IYSNAKNTEALPPPT	COLGALT2	601	Q8IYK4
LQYESEILPSTPNPQ	DUSP5	311	Q16690
ESRPLYSPLQPDIEQ	DYSF	1766	O75923
NLKAANTDPTAPPYD	CDH3	761	P22223
YQDSLPSLPVPSLEE	CROT	16	Q9UKG9
LYLPQEPTSEETPRT	PKN3	516	Q6P5Z2
NDNAPEILYPALPTD	PCDHGA1	556	Q9Y5H4
QPVDILSPQLYPGTT	FREM3	696	P0C091
QPSPNDRSLYLSPKS	GOLGA8A	71	A7E2F4
DKTLLYNPFPPTNES	UTP4	616	Q969X6
RYDLIQNSESPASPP	TNRC6C	1346	Q9HCJ0
TDNIQRFSSLPPYLP	TMEM132C	36	Q8N3T6
LSQISPPPDLDQIFY	F5	1451	P12259
STSSPYPLPEEIRNL	SKAP2	6	O75563
PLTSSYRDVPQPLFN	SEC24A	226	O95486
YLSLQTTTLPPAQPA	PML	826	P29590
PSLLSPYSDEDTTQP	HIF3A	641	Q9Y2N7
QALPNDILFSTTPPY	SIPA1L2	1511	Q9P2F8
RSLTLYPSQPSNPLV	SIGLEC7	291	Q9Y286
ALQQALLSPTPPDYT	SIK3	946	Q9Y2K2
YPAELPQSSPADSEQ	SHROOM1	356	Q2M3G4
DNDPQGYLSQPLSLL	MYCBP2	1521	O75592
YSPIGDDVQLLPTPS	ARHGAP5	991	Q13017
ENSSYLPNPLASPAL	RNF220	11	Q5VTB9
STQEPPYQVLSPDAT	STARD9	801	Q9P2P6
PATLSPSTIPQLTYD	PIAS1	86	O75925
YTSQVSAPLPIPDLA	NPAP1	416	Q9NZP6
DPTYQERAAPQTQPL	NOTCH4	1356	Q99466
PPPQLGYAVSDENLT	POM121L2	336	Q96KW2
SLPLPDQYPPSQITD	CLCA4	746	Q14CN2
DYTPPLLTTISPEQE	CLASRP	91	Q8N2M8
QDPSLPYPKEDNTLL	WASHC5	996	Q12768
YPTLQPEAAPSTQLG	ZBTB45	361	Q96K62
ESFLPQLLAYPNPID	UBE2H	106	P62256
YPPPSSTILANIVNA	RNPC3	161	Q96LT9
VEFPLPPSSYILSNN	PGC	326	P20142
YDPINPDRETLDQPS	TMEM143	126	Q96AN5
LAPPEVPQTYQDTAL	SPEG	2681	Q15772
IPYQESETQAVPLPL	SSH2	991	Q76I76
DLQVIPLTYPLDPTT	UBA7	506	P41226
QLTPLSSSQESYLPP	IGSF9B	911	Q9UPX0
DADPYNPVLPTNRAS	RPAP3	161	Q9H6T3
PPYQGLSPEESVNVL	STAT6	701	P42226
PQPQSTDYPRAADLA	ZBTB41	841	Q5SVQ8
QPDYPAERSSLIPIS	SAP130	446	Q9H0E3
TELPPEYLTSPLSQQ	HGS	231	O14964
EYLTSPLSQQSQLPP	HGS	236	O14964
PYPPALQSQLSITAN	NF1	2761	P21359
LTFDLTKYPDANPNP	SMC1A	1216	Q14683
PALAVLPIYSQLPSD	DHX38	771	Q92620
IFTAQLQLYSPPSPS	ROS1	171	P08922
LLSYLGPPDLPTNNN	ZMIZ2	896	Q8NF64
LETYNTCDTPPPLNN	WASF2	121	Q9Y6W5
PNPSDPYFSTLENSI	TPCN1	256	Q9ULQ1
LDYLTAPNPPSIREE	MID2	396	Q9UJV3
LSFSPNLDDYNPDIP	SORCS1	981	Q8WY21
SPPDTPSLREQAFYN	RIPOR1	351	Q6ZS17
QDPPKPSLSSQQAVY	TFR2	306	Q9UP52
IDVPSYLPDLPSIAN	WASH6P	226	Q9NQA3
ASYDTNGLSQPPLPE	TNS2	1061	Q63HR2
QGPSPLDLNTELPYQ	TTLL7	11	Q6ZT98
PQSPYASNLSPDTQL	TPRX2	241	P0DV77
ELTNPDELLSYLDPP	ZMIZ1	1036	Q9ULJ6
DELLSYLDPPDLPSN	ZMIZ1	1041	Q9ULJ6
YLDPPDLPSNSNDDL	ZMIZ1	1046	Q9ULJ6
DSPYNFSNPPITSLE	ZFHX3	2206	Q15911
TELDYSVNPESLPPL	MYO5C	46	Q9NQX4
LPSQPDYNSSKIPSA	MYOT	101	Q9UBF9